Prototype Web Portal Shows Technology’s Potential to Protect and Streamline the Clinical Trials Process
UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results—such as making the treatment look more effective or diminishing side effects.
“Everyone is talking about how blockchain is going to revolutionize many of the data challenges in medicine, and here is one use that finally might make sense,” said Atul Butte, MD, PhD, who is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF. “We think it could someday be useful for pharma companies running clinical trials.”
The research was published February 22 in Nature Communications.
Blockchain technology utilizes an old computer science technique known as hashing, which creates a unique digital signature for each so-called block of data. The hashes accumulate sequentially, as new data is entered or changed, with each block depending on the last. The resulting “blockchain” creates an audit trail for regulators that is easy to decipher and validate, even without looking at the actual data.
Daniel Wong, a PhD candidate in Biological and Medical Informatics at UCSF, built the system to operate through a web portal, so that each time new data is entered on a given trial participant, the sender, receiver, timestamp, and file attachment containing the data, along with the hash of the previous block of data pertaining to that patient, is recorded onto a new block, with its own distinct signature.
Unlike the decentralized nature of most blockchain applications, this clinical trial prototype depends on having a regulator with centralized authority, such as the U.S. Food and Drug Administration, to operate the web portal, register all parties, and keep a ledger of the blockchain’s hashes.
Data, including adverse events, would be reported to the regulatory agency in real time, which may provide a boost to the safety and efficiency of clinical trials. While the prototype makes allowances for data entry or other errors to be corrected, new data can only be appended to the existing chain, without erasing what was there before.
“It makes it really obvious when someone’s changing something,” Wong said. “You can see who put their hands on it, who made it, who changed it, and who received it.”
Wong tested the system with a small subset of data from a real, previously run phase II trial included in ImmPort, a repository of open clinical trial data funded by the National Institutes of Allergy and Infectious Diseases (NIAID) that is managed by Butte’s lab and collaborators.
After entering the original data, he logged in as the trial sponsor and tried to erase adverse events that had been reported for two patients in their case report forms. Instead of deleting those reports, however, the system appended his changes to the original data, making it clear who had tried to corrupt the forms, when it was done, and what had been changed.
Wong also tried corrupting the data stored from an earlier point in the trial, when patients were assigned to different treatment arms—drug or placebo—to make it look as though they had been given a different medication plan. But the blockchain ledger pinpointed exactly what had changed and when.
A prototype system like this reduces risks, but does not completely protect data from tampering. Even within a system enabled with this type of blockchain technology, the authors pointed out, it is still possible that those seeing patients at the point of care could enter wrong or incorrect data at the outset.
But blockchain technology could enable trials to be conducted under challenging conditions, or open doors to data exchanges that are more secure, more efficient, and more transparent for both researchers and the general public.
“A system built upon our prototype could be developed to enable oversight of international clinical trials, for example,” Butte said. “And it could be expanded to provide more access to raw data for research scientists, the way we do with ImmPort, or deliver trial results to the public.”
The Latest on: Blockchain
via Google News
The Latest on: Blockchain
- In 2019, Students Demanded Blockchain Education. In 2020, It’s Comingon December 15, 2019 at 7:39 am
With startups and Fortune 500 companies in dire need of blockchain talent, and the average U.S. salary for a blockchain developer at $130,000, now is a good time for students to get an education in ...
- Even if a Thousand Projects Don’t Make It, Blockchain Is Still a Change Catalyston December 15, 2019 at 6:36 am
This post is part of CoinDesk's 2019 Year in Review, a collection of 100 op-eds, interviews and takes on the state of blockchain and the world. Gary Gensler is a professor at the MIT Sloan School of ...
- AE Ventures to Invest in Four new Blockchain Startupson December 14, 2019 at 4:23 pm
MALTA, Dec. 13, 2019 (GLOBE NEWSWIRE) -- (via Blockchain Wire) -- AE Ventures, an investment company that provides initial funding, acceleration, and advisory support to blockchain projects, today ...
- TikTok Owner Forms JV With State Media in Blockchain, AIon December 13, 2019 at 8:46 pm
ByteDance Inc., the owner of TikTok, started a joint venture with a state-owned Chinese media group to develop business lines, including artificial intelligence and blockchain. A unit of ByteDance has ...
- Blockchain As A Service Market Technological Growth and Precise Outlook 2019on December 13, 2019 at 8:05 pm
Dec 14, 2019 (Market Insight Reports via COMTEX) -- The global Blockchain As A Service Market research report is a valuable source of insightful data for business strategists. It provides the industry ...
- 75% of IoT Firms Want to Add Blockchain: Surveyon December 13, 2019 at 1:33 pm
While there are still few large-scale use cases of blockchain, the Internet of Things (IoT) industry turns out to be “a sweet spot” for the adoption of such technologies. Avivah Litan, an IT industry ...
- Mike Cagney's new firm says it's giving banks 'a compelling reason' to use blockchainon December 13, 2019 at 11:23 am
Figure Technologies appears to be one of the few companies to find a viable use case for blockchain in the financial industry — cutting down the costs associated with loan origination. Earlier this ...
- Blockchain Distributed Ledger Market to Witness CAGR of 52.4% Rise in Value Share During the Period 2019-2025on December 13, 2019 at 10:07 am
Dec 13, 2019 (Market Insight Reports via COMTEX) -- The Blockchain Distributed Ledger Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2019-2025. The Blockchain ...
- Twitter To Move Platform To Blockchain: What Does This Mean For Users?on December 12, 2019 at 8:36 pm
Jack Dorsey wants to shift Twitter on blockchain platform. Dorsey believes that social media is focused on content and conversation that sparks controversy and outrage, rather than conversation which ...
- Managing Pension Risk With Amazon Managed Blockchainon December 12, 2019 at 8:02 pm
Contrast this with consumer insurance policies that can be set up in a few clicks. At Legal & General (L&G), we use blockchain to break through these challenges to make complex reinsurance more ...
via Bing News